Program eligibility is based on your insurance status
Alternatively, consider working with a therapist to address needle phobia before ruling out more effective injectable options
CJC 1295 : The potential side effects associated with this peptide include mild water retention
Health Canada's public advisory on unauthorized and counterfeit GLP-1 receptor agonist products, last updated January 21, 2026, instructs Canadians to verify any prescription product by checking for an eight-digit Drug Identification Number (DIN) on the label and searching Health Canada's Drug Product Database before purchase
If you are currently taking semaglutide (Wegovy, Ozempic or Rybelsus) and notice sudden loss of vision or other vision changes, you should seek urgent medical assistance and urgently attend eye casualty or A&E
By working through both pathways, tirzepatide provides broader support for appetite control, glucose balance, and overall metabolic function than single-receptor GLP-1 therapy alone